Search
Spotlight
Diabetic Eye Disease Viewpoint
Carl Zeiss Case Studies
Retina in 2020
Clinical
Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina
Articles
Media
Medical World News
Podcasts
Viewpoints
Publications
Digital Edition
Conferences
Resources
CME/CE
Sponsored Resources
Zeiss Case Studies
Subscribe
eNewsletter
Print Subscription
Search
Spotlight
Diabetic Eye Disease Viewpoint
Carl Zeiss Case Studies
Retina in 2020
Clinical
See All >
Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina
FDA grants orphan status to two Lux products
March 1, 2007
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
Related Article >>>